• レポートコード:PMR2008043 • 出版社/出版日:Persistence Market Research / 2020年5月28日 • レポート形態:英文、PDF、239ページ • 納品方法:Eメール • 産業分類:生命科学 |
Individual User(1名用) | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User(5名用) | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User(企業用) | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、インフルエンザ診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルスの危機分析、テスト種類別(分子診断テスト、従来型診断テスト)分析、インフルエンザ種類別(A型インフルエンザ、B型インフルエンザ、C型インフルエンザ)分析、エンドユーザー別(病院、診断研究所、学術研究機関、受託研究機関(CRO))分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルスの危機分析 ・インフルエンザ診断の世界市場規模:テスト種類別(分子診断テスト、従来型診断テスト) ・インフルエンザ診断の世界市場規模:インフルエンザ種類別(A型インフルエンザ、B型インフルエンザ、C型インフルエンザ) ・インフルエンザ診断の世界市場規模:エンドユーザー別(病院、診断研究所、学術研究機関、受託研究機関(CRO)) ・インフルエンザ診断の世界市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Influenza Diagnostics Market – Scope of the Report
The latest publication by Persistence Market Research (PMR) on the global influenza diagnostics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global influenza diagnostics market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the influenza diagnostics market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for successful growth in the influenza diagnostics market are presented in this comprehensive report, including Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers in knowing the demand for influenza diagnostics and quantitative development opportunities during the study period.
The research is beneficial for shareholders in influenza diagnostics, including influenza diagnostics market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the influenza diagnostics market. The insights and wisdom presented in PMR’s study can be leveraged by shareholders in the influenza diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to macro- as well as micro-economic variables affecting the business scenario in the influenza diagnostics market are also included in the study. Depending on potential developments in the influenza diagnostics market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the influenza diagnostics industry can make suitable business choices to achieve traction in the influenza diagnostics market.
Key Questions Answered in PMR’s Influenza Diagnostics Market Report
Which regions will continue to remain the most profitable regional markets for influenza diagnostics market players?
Which factors will induce a change in the demand for influenza diagnostics during the assessment period?
How will changing trends impact the influenza diagnostics market?
How can market players capture the low-hanging opportunities in the influenza diagnostics market in developed regions?
What are the winning strategies of stakeholders in the influenza diagnostics market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and tackle while investing in the influenza diagnostics market?
What are the developmental trends in influenza diagnostics sectors that will impact the market?
How can businesses in the influenza diagnostics market avail the growth opportunities in developed and emerging sectors?
Influenza Diagnostics Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the influenza diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the influenza diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the influenza diagnostics market, and makes PMR’s projections on the growth prospects of the influenza diagnostics market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product type Innovation / Development Trends
4. Key Success Factors
4.1. Influenza Diagnostics Adoption Rate/Usage Analysis- Key Statistics
4.2. Key Promotional Strategies, By Key Manufacturers
4.3. Key Regulations, By Region
4.4. Disease Epidemiology
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
1.1.1. Global Healthcare Industry Market Outlook
1.1.2. Global Life Science Market Outlook
5.2. Forecast Factors – Relevance & Impact
1.1.3. Key Players Historical Growth
1.1.4. Product Adoption Across Regions
1.1.5. Product cost
1.1.6. Disease Prevalence
1.1.7. In-patient Statistics
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2020 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Country
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Influenza Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Test Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Test Type, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2020-2030
8.3.1. Molecular Diagnostic Tests
8.3.1.1. RT-PCR
8.3.1.2. LAMP
8.3.1.3. NASBA
8.3.2. Traditional Diagnostic Tests
8.3.2.1. Rapid Influenza Detection Tests
8.3.2.2. Serological Assays
8.3.2.3. Direct Fluorescent Antibody
8.3.2.4. Viral Culture
8.3.2.5. H1N1 Influenza A Virus Identification Kits
8.3.2.6. Immunoassay Kits
8.3.2.7. Immunofluorescence Antibody Assay
8.4. Market Attractiveness Analysis By Test Type
9. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Type of Flu , 2015-2019
9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Type of Flu , 2020-2030
9.3.1. Type A Flu
9.3.2. Type B Flu
9.3.3. Type C Flu
9.4. Market Attractiveness Analysis By Test Type
10. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and By End User, 2015-2019
10.3. Current and Future Market Size (US$ Mn) and Forecast By End User, 2020-2030
10.3.1.1. Hospitals
10.3.1.2. Diagnostic Laboratories
10.3.1.3. Research and Academic Institute
10.3.1.4. Contract research organization (CROs)
10.4. Market Attractiveness Analysis by End User
11. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Test Type
12.3.3. By Type of Flu
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Test Type
13.3.3. By Type of Flu
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Test Type
14.3.3. By Type of Flu
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Test Type
15.3.3. By Type of Flu
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Test Type
16.3.3. By Type of Flu
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Test Type
17.3.3. By Type of Flu
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Test Type
18.3.3. By Type of Flu
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Key and Emerging Countries Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Influenza Diagnostics Market Analysis
19.2.1. By Test Type
19.2.2. By Type of Flu
19.2.3. By End User
19.3. Canada Influenza Diagnostics Market Analysis
19.3.1. By Test Type
19.3.2. By Type of Flu
19.3.3. By End User
19.4. Mexico Influenza Diagnostics Market Analysis
19.4.1. By Test Type
19.4.2. By Type of Flu
19.4.3. By End User
19.5. Brazil Influenza Diagnostics Market Analysis
19.5.1. By Test Type
19.5.2. By Type of Flu
19.5.3. By End User
19.6. U.K. Influenza Diagnostics Market Analysis
19.6.1. By Test Type
19.6.2. By Type of Flu
19.6.3. By End User
19.7. Germany Influenza Diagnostics Market Analysis
19.7.1. By Test Type
19.7.2. By Type of Flu
19.7.3. By End User
19.8. France Influenza Diagnostics Market Analysis
19.8.1. By Test Type
19.8.2. By Type of Flu
19.8.3. By End User
19.9. Italy Influenza Diagnostics Market Analysis
19.9.1. By Test Type
19.9.2. By Type of Flu
19.9.3. By End User
19.10. Spain Influenza Diagnostics Market Analysis
19.10.1. By Test Type
19.10.2. By Type of Flu
19.10.3. By End User
19.11. BENELUX Influenza Diagnostics Market Analysis
19.11.1. By Test Type
19.11.2. By Type of Flu
19.11.3. By End User
19.12. Russia Influenza Diagnostics Market Analysis
19.12.1. By Test Type
19.12.2. By Type of Flu
19.12.3. By Age Group
19.13. China Influenza Diagnostics Market Analysis
19.13.1. By Test Type
19.13.2. By Type of Flu
19.13.3. By End User
19.14. Japan Influenza Diagnostics Market Analysis
19.14.1. By Test Type
19.14.2. By Type of Flu
19.14.3. By End User
19.15. South Korea Influenza Diagnostics Market Analysis
19.15.1. By Test Type
19.15.2. By Type of Flu
19.15.3. By End User
19.16. India Influenza Diagnostics Market Analysis
19.16.1. By Test Type
19.16.2. By Type of Flu
19.16.3. By End User
19.17. Indonesia Influenza Diagnostics Market Analysis
19.17.1. By Test Type
19.17.2. By Type of Flu
19.17.3. By End User
19.18. Australia Influenza Diagnostics Market Analysis
19.18.1. By Test Type
19.18.2. By Type of Flu
19.18.3. By End User
19.19. New Zealand Influenza Diagnostics Market Analysis
19.19.1. By Test Type
19.19.2. By Type of Flu
19.19.3. By End User
19.20. GCC Countries Influenza Diagnostics Market Analysis
19.20.1. By Test Type
19.20.2. By Type of Flu
19.20.3. By End User
19.21. Turkey Influenza Diagnostics Market Analysis
19.21.1. By Test Type
19.21.2. By Type of Flu
19.21.3. By End User
19.22. South Africa Influenza Diagnostics Market Analysis
19.22.1. By Test Type
19.22.2. By Type of Flu
19.22.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1.1. Regional footprint of Players
20.3.1.2. Product type foot print by Players
20.3.1.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Abbott Laboratories
21.3.1.1. Overview
21.3.1.2. Product type Portfolio
21.3.1.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Analyst Commentary
21.3.1.6. Strategy Overview
21.3.1.6.1. Marketing Strategy
21.3.1.6.2. Product type Strategy
21.3.1.6.3. Channel Strategy
21.3.2. Endress+Hauser (Analytik Jena AG)
21.3.2.1. Overview
21.3.2.2. Product type Portfolio
21.3.2.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Analyst Commentary
21.3.2.6. Strategy Overview
21.3.2.6.1. Marketing Strategy
21.3.2.6.2. Product type Strategy
21.3.2.6.3. Channel Strategy
21.3.3. Becton, Dickinson and Company
21.3.3.1. Overview
21.3.3.2. Product type Portfolio
21.3.3.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Analyst Commentary
21.3.3.6. Strategy Overview
21.3.3.6.1. Marketing Strategy
21.3.3.6.2. Product type Strategy
21.3.3.6.3. Channel Strategy
21.3.4. Biocartis
21.3.4.1. Overview
21.3.4.2. Product type Portfolio
21.3.4.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Analyst Commentary
21.3.4.6. Strategy Overview
21.3.4.6.1. Marketing Strategy
21.3.4.6.2. Product type Strategy
21.3.4.6.3. Channel Strategy
21.3.5. bioMérieux Inc
21.3.5.1. Overview
21.3.5.2. Product type Portfolio
21.3.5.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Analyst Commentary
21.3.5.6. Strategy Overview
21.3.5.6.1. Marketing Strategy
21.3.5.6.2. Product type Strategy
21.3.5.6.3. Channel Strategy
21.3.6. Danaher Corporation (Cepheid)
21.3.6.1. Overview
21.3.6.2. Product type Portfolio
21.3.6.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Analyst Commentary
21.3.6.6. Strategy Overview
21.3.6.6.1. Marketing Strategy
21.3.6.6.2. Product type Strategy
21.3.6.6.3. Channel Strategy
21.3.7. F. Hoffmann-La Roche Ltd
21.3.7.1. Overview
21.3.7.2. Product type Portfolio
21.3.7.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Analyst Commentary
21.3.7.6. Strategy Overview
21.3.7.6.1. Marketing Strategy
21.3.7.6.2. Product type Strategy
21.3.7.6.3. Channel Strategy
21.3.8. GenMark Diagnostics, Inc.
21.3.8.1. Overview
21.3.8.2. Product type Portfolio
21.3.8.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Analyst Commentary
21.3.8.6. Strategy Overview
21.3.8.6.1. Marketing Strategy
21.3.8.6.2. Product type Strategy
21.3.8.6.3. Channel Strategy
21.3.9. Luminex Corporation
21.3.9.1. Overview
21.3.9.2. Product type Portfolio
21.3.9.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Analyst Commentary
21.3.9.6. Strategy Overview
21.3.9.6.1. Marketing Strategy
21.3.9.6.2. Product type Strategy
21.3.9.6.3. Channel Strategy
21.3.10. Meridian Bioscience, Inc
21.3.10.1. Overview
21.3.10.2. Product type Portfolio
21.3.10.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Analyst Commentary
21.3.10.6. Strategy Overview
21.3.10.6.1. Marketing Strategy
21.3.10.6.2. Product type Strategy
21.3.10.6.3. Channel Strategy
21.3.11. Quidel Corporation
21.3.11.1. Overview
21.3.11.2. Product type Portfolio
21.3.11.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Analyst Commentary
21.3.11.6. Strategy Overview
21.3.11.6.1. Marketing Strategy
21.3.11.6.2. Product type Strategy
21.3.11.6.3. Channel Strategy
21.3.12. Thermo Fisher Scientific Inc.
21.3.12.1. Overview
21.3.12.2. Product type Portfolio
21.3.12.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Analyst Commentary
21.3.12.6. Strategy Overview
21.3.12.6.1. Marketing Strategy
21.3.12.6.2. Product type Strategy
21.3.12.6.3. Channel Strategy
21.3.13. Hologic
21.3.13.1. Overview
21.3.13.2. Product type Portfolio
21.3.13.3. Profitability by Market Segments (Product type/Channel/Region)
21.3.13.4. Sales Footprint
21.3.13.5. Analyst Commentary
21.3.13.6. Strategy Overview
21.3.13.6.1. Marketing Strategy
21.3.13.6.2. Product type Strategy
21.3.13.6.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
List of TableTable 1: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 2: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 3: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 4: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 5: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 6: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 7: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 8: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 9: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 10: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 11: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 12: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 13: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 14: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 15: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 16: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 17: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 18: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 19: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 20: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 21: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 22: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 23: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 24: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 25: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 26: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 27: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 28: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 29: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type
Table 30: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu
Table 31: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 32: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country